BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 38460270)

  • 1. Structure-based discovery of potent CARM1 inhibitors for colorectal cancer therapy.
    Liu C; Li Y; Liu Z; Cao C; Lin M; Chen X; Yuan M; Fan Y; Gu X; Wang L; Yang F; Ye F; Jin J
    Eur J Med Chem; 2024 Apr; 269():116288. PubMed ID: 38460270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification, Synthesis, and Biological Evaluations of Potent Inhibitors Targeting Type I Protein Arginine Methyltransferases.
    Li X; Zhang L; Xu J; Liu C; Zhang X; Abdelmoneim AA; Zhang Q; Ke J; Zhang Y; Wang L; Yang F; Luo C; Jin J; Ye F
    J Chem Inf Model; 2022 Feb; 62(3):692-702. PubMed ID: 35098713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of Potent and Selective Coactivator-Associated Arginine Methyltransferase 1 (CARM1) Degraders.
    Xie H; Bacabac MS; Ma M; Kim EJ; Wang Y; Wu W; Li L; Xu W; Tang W
    J Med Chem; 2023 Sep; 66(18):13028-13042. PubMed ID: 37703322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of (2-(Benzyloxy)phenyl)methanamine Derivatives as Potent and Selective Inhibitors of CARM1 for the Treatment of Melanoma.
    Liu Z; Lin M; Liu C; Chen X; Chen Q; Li X; Wu X; Wang Y; Wang L; Yang F; Luo C; Jin J; Ye F
    J Med Chem; 2024 Apr; 67(8):6313-6326. PubMed ID: 38574345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unraveling the complexity of histone-arginine methyltransferase CARM1 in cancer: From underlying mechanisms to targeted therapeutics.
    Jin W; Zhang J; Chen X; Yin S; Yu H; Gao F; Yao D
    Biochim Biophys Acta Rev Cancer; 2023 Jul; 1878(4):188916. PubMed ID: 37196782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential CARM1 expression in prostate and colorectal cancers.
    Kim YR; Lee BK; Park RY; Nguyen NT; Bae JA; Kwon DD; Jung C
    BMC Cancer; 2010 May; 10():197. PubMed ID: 20462455
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A hypermethylation strategy utilized by enhancer-bound CARM1 to promote estrogen receptor α-dependent transcriptional activation and breast carcinogenesis.
    Peng BL; Li WJ; Ding JC; He YH; Ran T; Xie BL; Wang ZR; Shen HF; Xiao RQ; Gao WW; Ye TY; Gao X; Liu W
    Theranostics; 2020; 10(8):3451-3473. PubMed ID: 32206101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-glucose-induced CARM1 expression regulates apoptosis of human retinal pigment epithelial cells via histone 3 arginine 17 dimethylation: role in diabetic retinopathy.
    Kim DI; Park MJ; Lim SK; Choi JH; Kim JC; Han HJ; Kundu TK; Park JI; Yoon KC; Park SW; Park JS; Heo YR; Park SH
    Arch Biochem Biophys; 2014 Oct; 560():36-43. PubMed ID: 25072916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histone arginine methyltransferase CARM1 selective inhibitor TP-064 induces apoptosis in endometrial cancer.
    Inoue F; Sone K; Toyohara Y; Tanimoto S; Takahashi Y; Kusakabe M; Kukita A; Honjoh H; Nishijima A; Taguchi A; Miyamoto Y; Tanikawa M; Iriyama T; Uchino MM; Tsuruga T; Wada-Hiraike O; Oda K; Osuga Y
    Biochem Biophys Res Commun; 2022 Apr; 601():123-128. PubMed ID: 35245741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Automethylation of CARM1 allows coupling of transcription and mRNA splicing.
    Kuhn P; Chumanov R; Wang Y; Ge Y; Burgess RR; Xu W
    Nucleic Acids Res; 2011 Apr; 39(7):2717-26. PubMed ID: 21138967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery and biological evaluation of novel CARM1/HDAC2 dual-targeting inhibitors with anti-prostate cancer agents.
    Liang S; Geng Y; Niu MM; Zhang Y; He W; Li J; Yang L; Xu Z
    J Enzyme Inhib Med Chem; 2023 Dec; 38(1):2241118. PubMed ID: 37528657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interplay among coactivator-associated arginine methyltransferase 1, CBP, and CIITA in IFN-gamma-inducible MHC-II gene expression.
    Zika E; Fauquier L; Vandel L; Ting JP
    Proc Natl Acad Sci U S A; 2005 Nov; 102(45):16321-6. PubMed ID: 16254053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coactivator-associated arginine methyltransferase 1 controls oligodendrocyte differentiation in the corpus callosum during early brain development.
    Ishino Y; Shimizu S; Tohyama M; Miyata S
    Dev Neurobiol; 2022 Apr; 82(3):245-260. PubMed ID: 35220691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CARM1 (PRMT4) Acts as a Transcriptional Coactivator during Retinoic Acid-Induced Embryonic Stem Cell Differentiation.
    Quintero CM; Laursen KB; Mongan NP; Luo M; Gudas LJ
    J Mol Biol; 2018 Oct; 430(21):4168-4182. PubMed ID: 30153436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of CARM1-Mediated Methylation of ACSL4 Promotes Ferroptosis in Colorectal Cancer.
    Feng S; Rao Z; Zhang J; She X; Chen Y; Wan K; Li H; Zhao C; Feng Y; Wang G; Hu J; Luo X
    Adv Sci (Weinh); 2023 Dec; 10(36):e2303484. PubMed ID: 37946697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The coactivator-associated arginine methyltransferase is necessary for muscle differentiation: CARM1 coactivates myocyte enhancer factor-2.
    Chen SL; Loffler KA; Chen D; Stallcup MR; Muscat GE
    J Biol Chem; 2002 Feb; 277(6):4324-33. PubMed ID: 11713257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of arginine methyltransferase CARM1 in androgen receptor function and prostate cancer cell viability.
    Majumder S; Liu Y; Ford OH; Mohler JL; Whang YE
    Prostate; 2006 Sep; 66(12):1292-301. PubMed ID: 16705743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural Studies Provide New Insights into the Role of Lysine Acetylation on Substrate Recognition by CARM1 and Inform the Design of Potent Peptidomimetic Inhibitors.
    Zhang Y; Marechal N; van Haren MJ; Troffer-Charlier N; Cura V; Cavarelli J; Martin NI
    Chembiochem; 2021 Dec; 22(24):3469-3476. PubMed ID: 34569136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A coactivator role of CARM1 in the dysregulation of β-catenin activity in colorectal cancer cell growth and gene expression.
    Ou CY; LaBonte MJ; Manegold PC; So AY; Ianculescu I; Gerke DS; Yamamoto KR; Ladner RD; Kahn M; Kim JH; Stallcup MR
    Mol Cancer Res; 2011 May; 9(5):660-70. PubMed ID: 21478268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Global mapping of CARM1 substrates defines enzyme specificity and substrate recognition.
    Shishkova E; Zeng H; Liu F; Kwiecien NW; Hebert AS; Coon JJ; Xu W
    Nat Commun; 2017 May; 8():15571. PubMed ID: 28537268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.